Для коментарів чи іншого зворотного зв'язку заповніть форму:
Форма зворотного зв'язку щодо цієї версії документу

Зображення 01355. Choice of prophylactic medication for atrial fibrillation

Автор: Finnish Current Care Guidelines / Working group on atrial fibrillation
Редактори оригінального тексту: -
Дата останнього оновлення: 2017-09-15

Choice of prophylactic medication for atrial fibrillation. The choice of prophylactic medication is essentially affected by other (cardiac) diseases of the patient. In outpatient care, the first-line drug is usually a beta blocker. Of the actual antiarrhythmic agents, Class IC drugs (flecainide) are the first-line drugs in lone atrial fibrillation. Quinidine and disopyramide (special regulatory restrictions may apply) are particularly suitable for the prevention of vagal AF. Structural heart disease is a contraindication for the use of Class I antiarrhythmic agents. The use of sotalol is restricted by the risk of torsades de pointes ventricular tachycardia. Amiodarone and dronedarone cause numerous extra-cardiac adverse effects which restricts their use. ACE inhibitors and angiotensin II receptor blockers (ARBs) appear to prevent the occurrence of AF in patients with heart failure and hypertension.